Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Use of artemether-lumefantrine to treat malaria during pregnancy: what do we know and need to know?

Mutabingwa TK, Adam I.

Expert Rev Anti Infect Ther. 2013 Feb;11(2):125-35. doi: 10.1586/eri.12.169.

PMID:
23409819
2.

[A randomized clinical trial comparing the effectiveness and tolerability of artemisinine-naphthoquine (Arco®) and artemether-lumefantrine (Coartem®) in the treatment of uncomplicated malaria in Benin].

Kinde-Gazard D, Ogouyèmi-Hounto A, Capo-Chichi L, Gbaguidi J, Massougbodji A.

Bull Soc Pathol Exot. 2012 Aug;105(3):208-14. doi: 10.1007/s13149-012-0211-7. Epub 2012 Feb 11. French.

PMID:
22328063
4.

Coartem(®): a decade of patient-centric malaria management.

Hamed K, Grueninger H.

Expert Rev Anti Infect Ther. 2012 Jun;10(6):645-59. doi: 10.1586/eri.12.51. Epub 2012 May 3.

PMID:
22554131
5.

Artemether-lumefantrine: an option for malaria.

Stover KR, King ST, Robinson J.

Ann Pharmacother. 2012 Apr;46(4):567-77. doi: 10.1345/aph.1Q539. Epub 2012 Apr 10. Review.

PMID:
22496476
6.

Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria.

Nyunt MM, Nguyen VK, Kajubi R, Huang L, Ssebuliba J, Kiconco S, Mwima MW, Achan J, Aweeka F, Parikh S, Mwebaza N.

Antimicrob Agents Chemother. 2015 Dec 14;60(3):1274-82. doi: 10.1128/AAC.01605-15.

7.

Artemether + lumefantrine: new drug. An alternative to atovaquone + proguanil.

[No authors listed]

Prescrire Int. 2008 Apr;17(94):54-6.

PMID:
18516806
8.

A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand.

Lefèvre G, Looareesuwan S, Treeprasertsuk S, Krudsood S, Silachamroon U, Gathmann I, Mull R, Bakshi R.

Am J Trop Med Hyg. 2001 May-Jun;64(5-6):247-56.

PMID:
11463111
9.

Safety profile of Coartem: the evidence base.

Falade C, Manyando C.

Malar J. 2009 Oct 12;8 Suppl 1:S6. doi: 10.1186/1475-2875-8-S1-S6. Review.

10.

Artemether-lumefantrine (Coartem) for treatment of malaria.

[No authors listed]

Med Lett Drugs Ther. 2009 Sep 21;51(1321):75-6. No abstract available.

PMID:
19763049
11.

A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand.

Hutagalung R, Paiphun L, Ashley EA, McGready R, Brockman A, Thwai KL, Singhasivanon P, Jelinek T, White NJ, Nosten FH.

Malar J. 2005 Sep 22;4:46.

12.

Artemether-lumefantrine: an oral antimalarial for uncomplicated malaria in children.

Adjei GO, Goka BQ, Binka F, Kurtzhals JA.

Expert Rev Anti Infect Ther. 2009 Aug;7(6):669-81. doi: 10.1586/eri.09.53. Review.

PMID:
19681693
13.

Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia.

Dunyo S, Sirugo G, Sesay S, Bisseye C, Njie F, Adiamoh M, Nwakanma D, Diatta M, Janha R, Sisay Joof F, Temple B, Snell P, Conway D, Walton R, Cheung YB, Milligan P.

PLoS One. 2011;6(6):e17371. doi: 10.1371/journal.pone.0017371. Epub 2011 Jun 7.

14.

A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda.

Fanello CI, Karema C, van Doren W, Van Overmeir C, Ngamije D, D'Alessandro U.

Trans R Soc Trop Med Hyg. 2007 Apr;101(4):344-50. Epub 2006 Sep 26.

PMID:
17005222
15.

Safe and efficacious artemisinin-based combination treatments for African pregnant women with malaria: a multicentre randomized control trial.

Nambozi M, Mulenga M, Halidou T, Tagbor H, Mwapasa V, Phiri LK, Kalanda G, Valea I, Traore M, Mwakazanga D, Claeys Y, Schurmans C, De Crop M, Menten J, Ravinetto R, Thriemer K, Van Geertruyden JP, Mutabingwa T, D'Alessandro U; Pregact Group.

Reprod Health. 2015 Jan 15;12:5. doi: 10.1186/1742-4755-12-5.

16.

A case-control auditory evaluation of patients treated with artemether-lumefantrine.

Hutagalung R, Htoo H, Nwee P, Arunkamomkiri J, Zwang J, Carrara VI, Ashley E, Singhasivanon P, White NJ, Nosten F.

Am J Trop Med Hyg. 2006 Feb;74(2):211-4.

PMID:
16474072
17.

The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine.

Djimde AA, Makanga M, Kuhen K, Hamed K.

Expert Rev Anti Infect Ther. 2015 Aug;13(8):1031-45. doi: 10.1586/14787210.2015.1052793. Epub 2015 Jun 16. Review.

PMID:
26081265
18.

Exposure to artemether-lumefantrine (Coartem) in first trimester pregnancy in an observational study in Zambia.

Manyando C, Njunju EM, Virtanen M, Hamed K, Gomes M, Van Geertruyden JP.

Malar J. 2015 Feb 14;14:77. doi: 10.1186/s12936-015-0578-6.

19.

Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India.

Valecha N, Srivastava P, Mohanty SS, Mittra P, Sharma SK, Tyagi PK, Pradhan K, Dev V, Singh R, Dash AP, Sharma YD.

Malar J. 2009 May 19;8:107. doi: 10.1186/1475-2875-8-107.

20.

Pharmacovigilance of artemether-lumefantrine in pregnant women followed until delivery in Rwanda.

Rulisa S, Kaligirwa N, Agaba S, Karema C, Mens PF, de Vries PJ.

Malar J. 2012 Jul 6;11:225. doi: 10.1186/1475-2875-11-225.

Supplemental Content

Support Center